IH is the ticker symbol for iHuman Inc., a publicly traded Consumer Discretionary sector company listed on NYSE. 13F Pro tracks IH with AI-powered analysis, a 32-signal quality score, SEC EDGAR financials, insider transactions, and institutional 13F holdings — all sourced directly from public SEC filings.

Is IH a good stock to buy?

IH is tracked on 13F Pro with SEC EDGAR data, but is not currently included in our 32-signal AI quality ranking. The full company profile with financials and AI insights is at https://13fpro.ai/company/IH.

Where does 13F Pro source IH data?

All iHuman Inc. fundamentals and ownership data come directly from SEC EDGAR. iHuman Inc. files with the SEC under CIK 1814423. 13F Pro ingests XBRL financial facts from 10-K and 10-Q filings, Form 13F-HR institutional holdings, and Form 4 insider transactions, with no third-party rewrites or estimates.

iHuman Inc.(IH)— Stock Profile, AI Score & Financials

Consumer Discretionary · NYSE · AI-powered stock analysis, 32-signal quality score, SEC EDGAR financials, and institutional holdings. Updated 2025-12-31.

iHuman Inc. (IH) stock profile, AI quality score, and SEC EDGAR financial data, a Consumer Discretionary sector company. IH is not currently included in 13F Pro's AI-ranked quality universe — quality rankings require at least 50 unique 13-f institutional holders to ensure peer comparisons are meaningful. only 8 institutional filers currently hold this stock. Based on the latest XBRL financial filings (FY 2025), iHuman Inc. reports quarterly revenue of $115.4M, net income of $13.6M, an operating margin of 8.3%. Top institutional holders of IH by reported 13-F value include MORGAN STANLEY, CITADEL ADVISORS, SUSQUEHANNA INTERNATIONAL GROUP, LLP, based on the most recent SEC filings. IH trades on the NYSE exchange and files with the SEC under CIK 1814423. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate IH daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for iHuman Inc. directly from SEC EDGAR.

Revenue

$115.4M

Net Income

$13.6M

Free Cash Flow

$6.6M

Operating Margin

8.3%

IH key financials by period

iHuman Inc. reported revenue, net income and margins by fiscal period, from SEC filings.
Period	Form	Revenue	Net income	Operating margin
FY 2025	20-F	$807.0M	$13.6M	1.2%
FY 2024	20-F	$922.2M	$98.6M	7.8%
FY 2023	20-F	$1.0B	$180.9M	15.7%
FY 2022	20-F	$985.5M	$109.8M	11.3%
FY 2021	20-F	$944.7M	$-37.1M	-5.7%
FY 2020	20-F	$531.9M	$-37.5M	-8.4%

Institutions holding IH

Institutional investors reporting a position in iHuman Inc. on SEC Form 13F.
Institution	Shares	Value	Reported
MORGAN STANLEY	38,000	$53.2K	2026-06-30
CITADEL ADVISORS	32,689	$45.8K	2026-06-30
SUSQUEHANNA INTERNATIONAL GROUP, LLP	16,945	$23.7K	2026-06-30
ACADIAN ASSET MANAGEMENT	15,067	$20.0K	2026-06-30
GOLDMAN SACHS GROUP	12,626	$17.7K	2026-06-30
CREDIT AGRICOLE S A	10,000	$14.0K	2026-06-30
BNP PARIBAS FINANCIAL MARKETS	4,200	$5.9K	2026-06-30
UBS Group AG	129	$181.00	2026-06-30

SEC EDGAR: CIK 1814423 →

iHuman Inc.

NYSESmall CapConsumer Discretionary

13F Pro Quality Score

Not in ranked universe

Limited institutional coverage

Quality rankings require at least 50 unique 13-F institutional holders to ensure peer comparisons are meaningful. Only 8 institutional filers currently hold this stock.

Financial data, filings, and institutional holdings below are still tracked in full — only the proprietary quality composite is unavailable for this name.